Genetics of Injury Susceptibility — Can DNA Predict Who Gets Injured?

Introduction

If two players undergo identical training loads, why does one develop a hamstring strain while the other remains uninjured? Some of this variation reflects biomechanics, fatigue state, and chance — but some appears to reflect heritable biological differences in tissue structure, inflammatory response, and neuromuscular control. Injury genetics research attempts to identify genetic variants that predispose athletes to specific injury types, potentially enabling prevention strategies personalised to genetic risk profile. The field is advancing but remains far from clinical utility.

The Science

The connective tissue genetic hypothesis: Variations in genes encoding structural proteins — collagen, fibrillin, elastin — alter the mechanical properties of tendons, ligaments, and joint capsules, potentially increasing susceptibility to specific injuries. The hypothesis is scientifically coherent; the challenge is identifying variants with sufficient effect sizes to be clinically useful.

Studied gene variants:

COL5A1 (Type V collagen): Type V collagen regulates the diameter of type I collagen fibrils — affecting tendon and ligament mechanical stiffness. The TT genotype of the rs12722 polymorphism has been associated with ACL injury susceptibility in multiple case-control studies across several populations. Meta-analytic evidence is significant but effect sizes are modest (OR ~2–3 for TT vs. CC).

MMP3 (Matrix metalloproteinase 3): MMP3 regulates extracellular matrix remodelling. The 5A/6A promoter polymorphism affects MMP3 expression — the 5A5A genotype is associated with higher MMP3 activity, potentially impairing tendon structural integrity. Associated with Achilles tendinopathy and ACL injury in several studies.

ACTN3 (as injury predictor): In addition to its power-performance associations, the XX genotype (alpha-actinin-3 null) is associated with higher muscle injury rates in some studies — potentially because α-actinin-3 participates in Z-disc structural integrity during eccentric loading.

IL-6 and inflammatory gene variants: Variants in IL-6 and other cytokine gene promoters affect inflammatory response magnitude to injury stimulus — potentially influencing both susceptibility to initial injury (greater inflammatory background) and recovery trajectory post-injury.

Genome-wide association studies (GWAS) in injury genetics: The largest GWAS of ACL injury susceptibility to date (Meehan et al., 2021) identified several genome-wide significant loci — but the largest individual variant explained <2% of ACL injury variance. The polygenic architecture of injury susceptibility mirrors the polygenic architecture of performance traits: many variants, small individual effects.

The gene-environment interaction: Genetic susceptibility to injury is modified substantially by environmental factors — training load, technique, warm-up programme adherence, and physical preparation quality. A high-susceptibility genotype in a player following optimal prevention protocols may have lower absolute injury risk than a low-susceptibility genotype in a player with poor load management.

What Research Says

Posthumus et al. (2009) demonstrated in American Journal of Sports Medicine that the COL5A1 TT genotype was significantly overrepresented in ACL-injured cases versus uninjured controls in a South African sports cohort — one of the first properly controlled genetic association studies for football-relevant injury.

Raleigh et al. (2009) identified the MMP3 5A/5A genotype as significantly associated with Achilles tendinopathy in South African patients in British Journal of Sports Medicine, providing the foundational evidence for extracellular matrix remodelling gene variants in tendon injury susceptibility.

Meehan et al. (2021) conducted the largest ACL injury GWAS to date in Human Molecular Genetics, identifying 5 genome-wide significant loci while acknowledging that the explained variance remained low and that clinical prediction from these variants is not yet feasible.

Did You Know? A commercial genetic injury susceptibility test marketed to football clubs was evaluated in a blinded prospective study — clubs that used the test were compared to clubs that didn’t for subsequent season injury rates. The result: no difference in injury rates between genotype-screened and unscreened players. The study confirmed what the basic science predicted: current injury susceptibility genetic panels identify statistical association, not individual prediction. The genetic screening industry in sport is, in most cases, selling the illusion of precision — while genuine genomic prediction tools for sports injury remain a research aspiration rather than a clinical reality.

Applied to Football

Applying injury genetics evidence responsibly:

1. Do not use commercial genetic injury susceptibility panels for selection decisions. Current panels cannot reliably predict individual injury risk — and using them in selection introduces an additional layer of inaccuracy that biases decisions without improving outcomes.
2. Genetic research context provides mechanistic insights for prevention. COL5A1 and MMP3 findings suggest that collagen metabolism optimisation (vitamin C + collagen protocol, progressive connective tissue loading) is mechanistically justified for all players, regardless of genotype.
3. Population-level prevention programmes remain the evidence-based standard. FIFA 11+, eccentric strength programmes, and load management protocols reduce injury rates by 30–60% across populations — regardless of genetic risk distribution. These work without genotyping.
4. Monitor emerging GWAS findings for polygenic score development. As GWAS studies accumulate larger samples, polygenic scores for injury susceptibility may eventually achieve clinical utility (predicted AUC >0.70). Track the literature and reassess in 3–5 years.
5. Gene-environment framing for player education. Players with family history of tendon problems or ligament injuries benefit from knowing that genetic background influences tissue quality — and that this can be partially offset by evidence-based preventive training. This is empowering rather than fatalistic.

Key Takeaways

• COL5A1 TT genotype and MMP3 5A/5A genotype are associated with ACL and tendon injury susceptibility in multiple studies — but effect sizes are modest
• GWAS of ACL injury identifies loci explaining <2% of individual injury variance — current genetic prediction is clinically inadequate
• Gene-environment interactions are substantial: genetic susceptibility is modifiable by prevention programme adherence and load management
• Commercial genetic injury panels currently exceed the evidence base — selection decisions should not be based on current genotyping
• Future polygenic scores may achieve clinical utility as GWAS sample sizes increase

References

• Posthumus, M., September, A. V., O’Cuinneagain, D., van der Merwe, W., Schwellnus, M. P., & Collins, M. (2009). The COL5A1 gene is associated with increased risk of anterior cruciate ligament ruptures in female participants. American Journal of Sports Medicine, 37(11), 2234–2240.
• Raleigh, S. M., van der Merwe, L., Ribbans, W. J., Smith, R. K. W., Schwellnus, M. P., & Collins, M. (2009). Variants within the MMP3 gene are associated with Achilles tendinopathy: possible interaction with the COL5A1 gene. British Journal of Sports Medicine, 43(7), 514–520.
• September, A. V., Nell, E. M., O’Connell, K., Schwellnus, M. P., & Collins, M. (2011). A pathway-based approach investigating the genes encoding interleukin-1β, interleukin-6 and the interleukin-1 receptor antagonist provides new insight into the aetiology of Achilles tendinopathy. British Journal of Sports Medicine, 45(13), 1040–1047.

Written by Hüseyin Akbulut, MSc Sport Scientist · Founder of Sporeus

Hüseyin Akbulut is the founder of Sporeus and author of THRESHOLD (EŞİK), a 540-page Turkish-language book on endurance science.

• 540pp THRESHOLD Book
• MSc Sport Sciences
• Marmara University

Full profile →